ESC 2021 | GREENNESS: Surprising New Protective Factor against Cardiovascular Disease

What Is “Greenness”? This factor—which generally refers to the proximity to vegetation, as measured by satellite pictures—could serve as a new protection against cardiovascular disease.

During five years (the total research time), this study compared individuals who lived in the lowest tercile of “greenness” with those who lived in the highest tercile (i.e., those who lived closer to nature).

Living in open spaces decreased the probability of acute myocardial infarction, atrial fibrillation, heart failure, ischemic heart disease, hypertension, or stroke by 16% (p < 0.001).

Those who lived in greener areas but still suffered from cardiovascular disease had a protective factor, presenting far fewer subsequent events than their urban peers.

During the study period, the City of Miami promoted a very ambitious program for planting trees and developing green spaces.

This allowed many people initially classified in the lowest tercile in 2011 to move to the middle or even the highest tercile by 2016.

These changes resulted in a 15-% decrease in new diagnoses of cardiovascular disease compared with subjects who remained in the lowest tercile (p < 0.001).

Although this association seems quite evident, how green spaces directly impact the development of cardiovascular disease is still unclear. While obvious data such as air quality, water, lifestyle, diet, classic risk factors, exercise, stress, or access to healthcare centers were adjusted for, others, such as socioeconomic factors, could not be taken into account.


Read also: ESC 2021 | Empagliflozin in Heart Failure with Reduced and Preserved Ejection Fraction.


The concept could be incorporated into patient education on healthy eating and regular exercise—ideally in nature, if possible.

If areas with sufficient nature or any type of open space do not exist in the neighborhood, the issue should be raised as a health concern before politicians, so that all people have equal access to these types of environments.

Original Title: Longitudinal impact of greenness on cardiovascular disease conditions.

Reference. Aitken W, presentado durante el congreso de la ESC en agosto 2021.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

TAVR and Anticoagulation: What Should We Do?

Transcatheter aortic valve replacement (TAVR) has consolidated as a valid strategy for certain groups of patients. However, approximately one third of those who require...

Direct Oral Anticoagulants for Ventricular Thrombus After STEMI

While the incidence of intracavitary thrombi after acute myocardial infarction (AMI) has decreased thanks to optimized primary angioplasty times, some studies report rates of...

AHA 2024 | VANISH2 Trial

Cardiac defibrillator implants (CDIs) have been shown to improve survival in patients with ischemic cardiomyopathy and ventricular tachycardia (VT). However, approximately one third of...

AHA 2024 | SUMMIT

It has been previously shown that the pharmacological treatment of obesity (semaglutide) can reduce cardiovascular events in patients with cardiac failure (CF) and preserved...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

CRABBIS Trial: Comparison of Different Provisional Stenting Sequences

Provisional stenting (PS) is the gold standard for percutaneous coronary intervention (PCI) in most patients with coronary bifurcation lesions (CBL). Moreover, recent studies such...

Prospective Analysis of the Feasibility of the PASCAL System for Transcatheter Mitral Repair: OneForAll Registry

Courtesy of Dr. Juan Manuel Pérez. Mitral transcatheter edge-to-edge repair (M-TEER) is an effective option for patients with severe mitral regurgitation who are at high...

Left Bundle Branch Block after TAVR: What Is Its Impact?

Courtesy of Dr. Juan Manuel Pérez. Left bundle branch block (LBBB) is a common complication following transcatheter aortic valve replacement (TAVR), which can be either...